MYX 0.95% $7.30 mayne pharma group limited

New Product Approvals, page-217

  1. 1,326 Posts.
    lightbulb Created with Sketch. 261
    With Mithra 50% down since agreement with
    Mayne in October 19. Belgium locking Down.
    Trump tomorrow cancelling European travel.
    Mithra having cashflow Problem. Debt to be
    serviced. This maybe Opportunity for Mayne
    to manufacture both Myring and E4 In US.
    with Mithras blessing. Huge Opportunity.
    Unfortunate for Mithra but we after all have
    to pay 5x Distribution costs of all Europe for
    E4 agreement.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$7.30
Change
-0.070(0.95%)
Mkt cap ! $617.6M
Open High Low Value Volume
$7.38 $7.40 $7.22 $404.2K 55.59K

Buyers (Bids)

No. Vol. Price($)
8 392 $7.30
 

Sellers (Offers)

Price($) Vol. No.
$7.31 285 6
View Market Depth
Last trade - 12.17pm 06/05/2024 (20 minute delay) ?
Last
$7.30
  Change
-0.070 ( 0.28 %)
Open High Low Volume
$7.40 $7.40 $7.22 8492
Last updated 12.36pm 06/05/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.